Psoriasis Treatment Market By Drug Class (TNF Inhibitors, Vitamin D Analogues, Interleukin Blockers, Topical Corticosteroids), By Type (Plaque Psoriasis, Guttate Psoriasis, Flexural Or Inverse Psoriasis, Psoriatic Arthritis) - Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Psoriasis is a chronic, inflammatory, painful skin disease; currently there is no cure primary goal of treatment is to reduce inflammation and abnormal skin plaque formation. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence, significant unmet needs, promising pipeline molecules would fuel the growth of psoriasis treatment market worldwide.  

The report titled “Psoriasis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall psoriasis treatment market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on drug class, type and different geographical regions. Geographically, the global psoriasis treatment market is studied for the following regional markets:   

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
• Middle East and Africa
  • GCC
  • Rest of MEA
  •  

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global psoriasis treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global psoriasis treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global psoriasis treatment market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global psoriasis treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.    

For the purpose of this study, the global psoriasis treatment market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

Psoriasis is a chronic, noncommunicable, painful skin disease for which there is no cure with great negative impact on patients quality of life, it can occur at any age, but more common older people. According to the International Federation of Psoriasis Associations (IFPA), about 3 percent of the world’s population has some form of psoriasis. In the base year 2016, North America dominated the psoriasis treatment market, United States is largest revenue contributor due to the upsurge in funding by government agencies and private organizations in healthcare system, higher cost of medication, higher number of psoriasis patient are factors fueling growth of psoriasis treatment market. 

According to the Cleveland Clinic, there are about 150,000 new cases of psoriasis every year in United States, approximately 2 percent of U.S. population is affected with psoriasis. Europe is the second largest revenue generating regional market for psoriasis treatment due to higher number of psoriasis patient have been reported in some European region such as Faroe Islands where about 2.8% of the population is affected with psoriasis. It is observed that, currently Asia Pacific is hold smallest market share due to the factors such as lowest Incidence rate in some countries such as japan, Australia, China, India; also comparatively lower cost of medication may hinder the growth of psoriasis treatment market in Asia Pacific.